Ingeborg Meijer
Ingeborg Meijer
Afiliación desconocida
Dirección de correo verificada de
TítuloCitado porAño
Isolation, expression, and the primary structure of HLA-Cw1 and HLA-Cw2 genes: evolutionary aspects
D Güssow, RS Rein, I Meijer, W de Hoog, GHA Seemann, ...
Immunogenetics 25 (5), 313-322, 1987
Differential effects of the adenovirus E1A oncogene on members of the AP-1 transcription factor family.
H van Dam, R Offringa, I Meijer, B Stein, AM Smits, P Herrlich, JL Bos, ...
Molecular and cellular biology 10 (11), 5857-5864, 1990
Societal output and use of research performed by health research groups
SP Mostert, SPH Ellenbroek, I Meijer, G Van Ark, EC Klasen
Health research policy and systems 8 (1), 30, 2010
The value of research data–Metrics for datasets from a cultural and technical point of view
R Costas, I Meijer, Z Zahedi, P Wouters
A Knowledge Exchange Report. Retrieved January 30, 2014, 2013
Reduced binding activity of transcription factor NF-κB accounts for MHC class I repression in adenovirus type 12 E1-transformed cells
I Meijer, AJM Boot, G Mahabir, A Zantema, AJ van Der Eb
Cellular immunology 145 (1), 56-65, 1992
Adenovirus type 12 E1A down regulates expression of a transgene under control of a major histocompatibility complex class I promoter: evidence for transcriptional control.
I Meijer, AG Jochemsen, CM De Wit, JL Bos, D Morello, AJ Van der Eb
Journal of virology 63 (9), 4039-4042, 1989
Transcriptional regulation of human papillomavirus type 16 LCR by different C/EBPβ isoforms
L Struyk, E Meijden, R Minnaar, V Fontaine, I Meijer, J Schegget
Molecular Carcinogenesis: Published in cooperation with the University of …, 2000
Networked research infrastructures and their governance: The case of biobanking.
I Meijer, J Molas-Gallart, P Mattsson
Science and Public Policy 39 (4), 491-499, 2012
Impacts of the Framework Programme in Sweden
E Arnold, T Åström, P Boekholt, N Brown, B Good, R Holmberg, I Meijer, ...
Stockholm: VINNOVA, 2008
Co-regulated expression of junB and MHC class I genes in adenovirus-transformed cells.
I Meijer, AJ Boot, JL Bos, A Zantema
Oncogene 6 (6), 911-916, 1991
Understanding the Long Term Impact of the Framework Programme
E Arnold, B Mahieu, J Stroyan, D Campbell, M Carlberg, F Giaracca, ...
European Policy Evaluation Consortium, 2011
Differential regulation of JunB and JunD by adenovirus type 5 and 12 E1A proteins.
I Meijer, C Mummery, W Kruijer
Oncogene 6 (12), 2357-2361, 1991
The role and added value of large-scale research facilities
F Zuijdam, P Boekholt, J Deuten, I Meijer, N Vermeulen
Group.[EB/OL]. 2011, 2011
Unwrapping “impact” for evaluation: A co-word analysis of the UK REF2014 policy documents using VOSviewer
GE Derrick, I Meijer, E van Wijk
Proceedings of the science and technology indicators conference, 145-154, 2014
Cord blood banking in the UK. An international comparison of policy and practice
I Meijer, M Knight, P Mattson, B Mostert, P Simmonds, W Vullings
Amended version January, 2009
Developing indicators on Open Access by combining evidence from diverse data sources
T van Leeuwen, I Meijer, A Yegros-Yegros, R Costas
arXiv preprint arXiv:1802.02827, 2018
Evaluation of the valorisation activities of the Netherlands Genomics Initiative
P Boekholt, I Meijer, W Vullings
Amsterdam, 2007
Monitoring the evolution and benefits of RRI: Report on the researchers’ survey
S Bührer, R Lindner, H Berghäuser, R Woolley, N Mejlgaard, ...
European Commission, Brussels, 2017
Monitoring the evolution and benefits of Responsible Research and Innovation in Europe: Summarising insights from the MoRRI project
V Peter, F Maier, N Mejlgaard, CW Bloch, EB Madsen, E Griessler, ...
European Commission DG Research and Innovation, 2018
Open Data: the researcher perspective-survey and case studies
S Berghmans, H Cousijn, G Deakin, I Meijer, A Mulligan, A Plume, ...
Mendeley Data, v1 http://dx. doi. org/10.17632/bwrnfb4bvh 1, 2017
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20